Ameritas Investment Company’s Precigen PGEN Stock Holding History

Ameritas Investment Company’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-17	Closed	–	–	1553
2018 Q4	$0	Buy	+17	New	+$191	﹤0.01%	1560

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Ameritas Investment Company's PGEN Position: Q1 2019 in Review

Ameritas Investment Company sold out of Precigen (PGEN) in Q1 2019, closing a stake of 17 shares.

Ameritas Investment Company first reported a position in PGEN in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2019.

Ameritas Investment Company reported no remaining Precigen position as of Q1 2019 after selling out during the quarter.
Ameritas Investment Company sold 17 Precigen shares in Q1 2019.
Ameritas Investment Company first reported a position in Precigen in Q4 2018 and held it in 1 quarter.
Ameritas Investment Company's Precigen position peaked at $0 in Q4 2018.
166 funds tracked by Wall St. Rank held Precigen as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.